Intentional low-molecular-weight heparin overdose: A case report and review

Blood Coagulation and Fibrinolysis

Volumn 23, Issue 8, 2012, Pages 772-774

  Byrne, Michael ^a   Zumberg, Marc ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

enoxaparin; heparin; low molecular weight; overdose; protamine sulfate

Indexed keywords

BLOOD CLOTTING FACTOR 10A INHIBITOR; BLOOD CLOTTING FACTOR 5 LEIDEN; ENOXAPARIN; HEMOGLOBIN; PROTAMINE SULFATE; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; ARTICLE; BLEEDING; BLOOD CELL COUNT; CASE REPORT; CAUCASIAN; CENTRAL VENOUS CATHETERIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; DISEASE DURATION; DRUG HALF LIFE; DRUG OVERDOSE; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FEMALE; GENE MUTATION; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HETEROZYGOSITY; HUMAN; IN VIVO STUDY; INTENSIVE CARE UNIT; LUNG EMBOLISM; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RETROPERITONEAL HEMATOMA; SELF INJECTION; SUICIDE ATTEMPT; THROMBOSIS; WRIST;

ADULT; ANTICOAGULANTS; BLOOD COAGULATION TESTS; DRUG OVERDOSE; ENOXAPARIN; FACTOR VIIA; FACTOR XA; FEMALE; HALF-LIFE; HEMORRHAGE; HUMANS; PROTAMINES; RECOMBINANT PROTEINS; SUICIDE, ATTEMPTED; VENOUS THROMBOEMBOLISM;

EID: 84870234436     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328358e8af     Document Type: Article

References (9)

1. Hirsh J, Raschke R. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126:188S-203S. (Pubitemid 39297954)
2. Lacy CF, Armstrong LL, Goldman MP, Lance LL. 2010 Drug information handbook. 18th ed. Hudson, OH: Lexi-Comp; 2010. pp. 1305-1306.
3. Bang C, Berstad A, Talstad L. Incomplete reversal of enoxaparin-induced bleeding by protamine sulfate. Haemostasis 1991; 21:155-160.
4. Chawla LS, Moore G, Seneff MG. Incomplete reversal of enoxaparin toxicity by protamine: implications of renal insufficiency, obesity, and low molecular weight heparin sulfate content. Obes Surg 2004; 14:695-698. (Pubitemid 38716594)
5. Makris M, Hough RE, Kitchen S. Poor reversal of low molecular weight heparin by protamine. Br J Haematol 2000; 108:884-885. (Pubitemid 30304529)
6. van Veen JJ, Maclean RM, Hamton KK, Laidlaw S, Kitchen S, Toth P, Makris M. Protamine reversal of low molecular weight heparin: clinically effective? Blood Coagul Fibrinolysis 2011; 22:565-570.
7. Wiernikowski JT, Chan A, Lo G. Reversal of antithrombin activity using protamine sulfate. Experience in a neonate with a 10-fold overdose of enoxaparin. Thromb Res 2007; 120:303-305. (Pubitemid 46881028)
8. Firozvi K, Deveras RA, Kessler CM. Reversal of low-molecular-weight heparin-induced bleeding in patients with preexisting hypercoagulable states with human recombinant activated factor VII concentrate. Am J Hematol 2006; 81:582-589. (Pubitemid 44066168)
9. Monte AA, Bodmer M, Schaeffer TH. Low-molecular-weight heparin overdose: management by observation. Ann Pharmacother 2010; 44:1836-1839.